These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 26040297)

  • 21. Effects of valproic acid, a histone deacetylase inhibitor, on improvement of locomotor function in rat spinal cord injury based on epigenetic science.
    Abdanipour A; Schluesener HJ; Tiraihi T
    Iran Biomed J; 2012; 16(2):90-100. PubMed ID: 22801282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Protective Effect of Repeated 1MeTIQ Administration on the Lactacystin-Induced Impairment of Dopamine Release and Decline in TH Level in the Rat Brain.
    Wąsik A; Romańska I; Zelek-Molik A; Nalepa I; Antkiewicz-Michaluk L
    Neurotox Res; 2018 Oct; 34(3):706-716. PubMed ID: 30129004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Valproate administered after traumatic brain injury provides neuroprotection and improves cognitive function in rats.
    Dash PK; Orsi SA; Zhang M; Grill RJ; Pati S; Zhao J; Moore AN
    PLoS One; 2010 Jun; 5(6):e11383. PubMed ID: 20614021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sodium valproate enhances doxorubicin-induced cognitive dysfunction in Wistar rats.
    Verma T; Mallik SB; Ramalingayya GV; Nayak PG; Kishore A; Pai KSR; Nandakumar K
    Biomed Pharmacother; 2017 Dec; 96():736-741. PubMed ID: 29049976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel HDAC inhibitors provide neuroprotection in MPTP-induced Parkinson's disease model of rats.
    Meka ST; Bojja SL; Kumar G; Birangal SR; Rao CM
    Eur J Pharmacol; 2023 Nov; 959():176067. PubMed ID: 37751833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of HDAC6, but not HDAC3 and HDAC4 in the penumbra after photothrombotic stroke in the rat cerebral cortex and the neuroprotective effects of α-phenyl tropolone, HPOB, and sodium valproate.
    Demyanenko SV; Dzreyan VA; Uzdensky AB
    Brain Res Bull; 2020 Sep; 162():151-165. PubMed ID: 32592806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of histone deacetylase, the ubiquitin proteasome system, and autophagy underlies the neuroprotective effects of venlafaxine in a rotenone-induced Parkinson's disease model in rats.
    El-Saiy KA; Sayed RH; El-Sahar AE; Kandil EA
    Chem Biol Interact; 2022 Feb; 354():109841. PubMed ID: 35104487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel histone deacetylase 1 and 2 isoform-specific inhibitor alleviates experimental Parkinson's disease.
    Choong CJ; Sasaki T; Hayakawa H; Yasuda T; Baba K; Hirata Y; Uesato S; Mochizuki H
    Neurobiol Aging; 2016 Jan; 37():103-116. PubMed ID: 26545632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The discovery of a highly selective 5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4(3H)-one SIRT2 inhibitor that is neuroprotective in an in vitro Parkinson's disease model.
    Di Fruscia P; Zacharioudakis E; Liu C; Moniot S; Laohasinnarong S; Khongkow M; Harrison IF; Koltsida K; Reynolds CR; Schmidtkunz K; Jung M; Chapman KL; Steegborn C; Dexter DT; Sternberg MJ; Lam EW; Fuchter MJ
    ChemMedChem; 2015 Jan; 10(1):69-82. PubMed ID: 25395356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Puerarin protects dopaminergic neurons against 6-hydroxydopamine neurotoxicity via inhibiting apoptosis and upregulating glial cell line-derived neurotrophic factor in a rat model of Parkinson's disease.
    Zhu G; Wang X; Chen Y; Yang S; Cheng H; Wang N; Li Q
    Planta Med; 2010 Nov; 76(16):1820-6. PubMed ID: 20509103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Valproic acid is neuroprotective in the rotenone rat model of Parkinson's disease: involvement of alpha-synuclein.
    Monti B; Gatta V; Piretti F; Raffaelli SS; Virgili M; Contestabile A
    Neurotox Res; 2010 Feb; 17(2):130-41. PubMed ID: 19626387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peripheral administration of the Class-IIa HDAC inhibitor MC1568 partially protects against nigrostriatal neurodegeneration in the striatal 6-OHDA rat model of Parkinson's disease.
    Mazzocchi M; Goulding SR; Morales-Prieto N; Foley T; Collins LM; Sullivan AM; O'Keeffe GW
    Brain Behav Immun; 2022 May; 102():151-160. PubMed ID: 35217173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histone hyperacetylation up-regulates protein kinase Cδ in dopaminergic neurons to induce cell death: relevance to epigenetic mechanisms of neurodegeneration in Parkinson disease.
    Jin H; Kanthasamy A; Harischandra DS; Kondru N; Ghosh A; Panicker N; Anantharam V; Rana A; Kanthasamy AG
    J Biol Chem; 2014 Dec; 289(50):34743-67. PubMed ID: 25342743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic effects of repetitive transcranial magnetic stimulation in an animal model of Parkinson's disease.
    Lee JY; Kim SH; Ko AR; Lee JS; Yu JH; Seo JH; Cho BP; Cho SR
    Brain Res; 2013 Nov; 1537():290-302. PubMed ID: 23998987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endogenous alpha-synuclein is induced by valproic acid through histone deacetylase inhibition and participates in neuroprotection against glutamate-induced excitotoxicity.
    Leng Y; Chuang DM
    J Neurosci; 2006 Jul; 26(28):7502-12. PubMed ID: 16837598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple molecular pathways are involved in the neuroprotection of GDNF against proteasome inhibitor induced dopamine neuron degeneration in vivo.
    Du Y; Li X; Yang D; Zhang X; Chen S; Huang K; Le W
    Exp Biol Med (Maywood); 2008 Jul; 233(7):881-90. PubMed ID: 18445767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Valproate increases dopamine transporter expression through histone acetylation and enhanced promoter binding of Nurr1.
    Green AL; Zhan L; Eid A; Zarbl H; Guo GL; Richardson JR
    Neuropharmacology; 2017 Oct; 125():189-196. PubMed ID: 28743636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electroacupuncture Therapy Ameliorates Motor Dysfunction via Brain-Derived Neurotrophic Factor and Glial Cell Line-Derived Neurotrophic Factor in a Mouse Model of Parkinson's Disease.
    Pak ME; Ahn SM; Jung DH; Lee HJ; Ha KT; Shin HK; Choi BT
    J Gerontol A Biol Sci Med Sci; 2020 Mar; 75(4):712-721. PubMed ID: 31644786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nobiletin protects dopaminergic neurons in the 1-methyl-4-phenylpyridinium-treated rat model of Parkinson's disease.
    Jeong KH; Jeon MT; Kim HD; Jung UJ; Jang MC; Chu JW; Yang SJ; Choi IY; Choi MS; Kim SR
    J Med Food; 2015 Apr; 18(4):409-14. PubMed ID: 25325362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nigral injection of a proteasomal inhibitor, lactacystin, induces widespread glial cell activation and shows various phenotypes of Parkinson's disease in young and adult mouse.
    Savolainen MH; Albert K; Airavaara M; Myöhänen TT
    Exp Brain Res; 2017 Jul; 235(7):2189-2202. PubMed ID: 28439627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.